NOVOZYMES BIOPHARMA UK LIMITED – Trademark Portfolio
Entity Type: 03
NOVOZYMES BIOPHARMA UK LIMITED holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ALBUFUSE and RECOMBUMIN. The owner is based in NOTTINGHAM, NG7 1FD.
CASTLE COURT
59 CASTLE BOULEVARD
NOTTINGHAM, NG7 1FD , GB
Showing of trademarks Trademarks
Trademark Classifications
NOVOZYMES BIOPHARMA UK LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does NOVOZYMES BIOPHARMA UK LIMITED have?
NOVOZYMES BIOPHARMA UK LIMITED has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 cancelled.
What trademark classes does NOVOZYMES BIOPHARMA UK LIMITED file in?
NOVOZYMES BIOPHARMA UK LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NOVOZYMES BIOPHARMA UK LIMITED's most well-known trademarks?
NOVOZYMES BIOPHARMA UK LIMITED's registered trademark portfolio includes well-known marks such as ALBUFUSE and RECOMBUMIN. These are among 2 currently registered trademarks in the portfolio.
What is NOVOZYMES BIOPHARMA UK LIMITED's trademark registration success rate?
NOVOZYMES BIOPHARMA UK LIMITED has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.